United States Sarcopenia Treatments Market Report & Forecast 2021-2027

Publisher Name :
Date: 24-Sep-2021
No. of pages: 94
Inquire Before Buying

United States Sarcopenia Treatments Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Sarcopenia Treatments Market Segment Percentages, By Type, 2020 (%)

- Protein Supplement

- Calcium Supplement

- Other

United States Sarcopenia Treatments Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Sarcopenia Treatments Market Segment Percentages, By Application, 2020 (%)

- Online Pharmacies

- Retail Pharmacies

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Sarcopenia Treatments revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Sarcopenia Treatments revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Abbott Laboratories

- Nestlé

- Pfizer

- Amway

- By-health

- Usana

- A&Z Pharmaceutical

- GlaxoSmithKline

- Bayer

- H&H

- Blackmores

- Zhendong Group

United States Sarcopenia Treatments Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Sarcopenia Treatments Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Sarcopenia Treatments Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Sarcopenia Treatments Overall Market Size
2.1 United States Sarcopenia Treatments Market Size: 2021 VS 2027
2.2 United States Sarcopenia Treatments Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sarcopenia Treatments Players in United States Market
3.2 Top United States Sarcopenia Treatments Companies Ranked by Revenue
3.3 United States Sarcopenia Treatments Revenue by Companies
3.4 Top 3 and Top 5 Sarcopenia Treatments Companies in United States Market, by Revenue in 2020
3.5 Companies Sarcopenia Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sarcopenia Treatments Players in United States Market
3.6.1 List of Tier 1 Sarcopenia Treatments Companies in United States
3.6.2 List of Tier 2 and Tier 3 Sarcopenia Treatments Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Sarcopenia Treatments Market Size Markets, 2021 & 2027
4.1.2 Protein Supplement
4.1.3 Calcium Supplement
4.1.4 Other
4.2 By Type - United States Sarcopenia Treatments Revenue & Forecasts
4.2.1 By Type - United States Sarcopenia Treatments Revenue, 2016-2021
4.2.2 By Type - United States Sarcopenia Treatments Revenue, 2022-2027
4.2.3 By Type - United States Sarcopenia Treatments Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Sarcopenia Treatments Market Size, 2021 & 2027
5.1.2 Online Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application - United States Sarcopenia Treatments Revenue & Forecasts
5.2.1 By Application - United States Sarcopenia Treatments Revenue, 2016-2021
5.2.2 By Application - United States Sarcopenia Treatments Revenue, 2022-2027
5.2.3 By Application - United States Sarcopenia Treatments Revenue Market Share, 2016-2027
6 Sarcopenia Treatments Companies Profiles
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Details
6.1.2 Abbott Laboratories Business Overview
6.1.3 Abbott Laboratories Sarcopenia Treatments Introduction
6.1.4 Abbott Laboratories Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.1.5 Abbott Laboratories Recent Developments
6.2 Nestlé
6.2.1 Nestlé Company Details
6.2.2 Nestlé Business Overview
6.2.3 Nestlé Sarcopenia Treatments Introduction
6.2.4 Nestlé Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.2.5 Nestlé Recent Developments
6.3 Pfizer
6.3.1 Pfizer Company Details
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Sarcopenia Treatments Introduction
6.3.4 Pfizer Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.3.5 Pfizer Recent Developments
6.4 Amway
6.4.1 Amway Company Details
6.4.2 Amway Business Overview
6.4.3 Amway Sarcopenia Treatments Introduction
6.4.4 Amway Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.4.5 Amway Recent Developments
6.5 By-health
6.5.1 By-health Company Details
6.5.2 By-health Business Overview
6.5.3 By-health Sarcopenia Treatments Introduction
6.5.4 By-health Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.5.5 By-health Recent Developments
6.6 Usana
6.6.1 Usana Company Details
6.6.2 Usana Business Overview
6.6.3 Usana Sarcopenia Treatments Introduction
6.6.4 Usana Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.6.5 Usana Recent Developments
6.7 A&Z Pharmaceutical
6.7.1 A&Z Pharmaceutical Company Details
6.7.2 A&Z Pharmaceutical Business Overview
6.7.3 A&Z Pharmaceutical Sarcopenia Treatments Introduction
6.7.4 A&Z Pharmaceutical Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.7.5 A&Z Pharmaceutical Recent Developments
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Company Details
6.8.2 GlaxoSmithKline Business Overview
6.8.3 GlaxoSmithKline Sarcopenia Treatments Introduction
6.8.4 GlaxoSmithKline Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.8.5 GlaxoSmithKline Recent Developments
6.9 Bayer
6.9.1 Bayer Company Details
6.9.2 Bayer Business Overview
6.9.3 Bayer Sarcopenia Treatments Introduction
6.9.4 Bayer Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.9.5 Bayer Recent Developments
6.10 H&H
6.10.1 H&H Company Details
6.10.2 H&H Business Overview
6.10.3 H&H Sarcopenia Treatments Introduction
6.10.4 H&H Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.10.5 H&H Recent Developments
6.11 Blackmores
6.11.1 Blackmores Company Details
6.11.2 Blackmores Business Overview
6.11.3 Blackmores Sarcopenia Treatments Introduction
6.11.4 Blackmores Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.11.5 Blackmores Recent Developments
6.12 Zhendong Group
6.12.1 Zhendong Group Company Details
6.12.2 Zhendong Group Business Overview
6.12.3 Zhendong Group Sarcopenia Treatments Introduction
6.12.4 Zhendong Group Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.12.5 Zhendong Group Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Sarcopenia Treatments Market Opportunities & Trends in United States Market
Table 2. Sarcopenia Treatments Market Drivers in United States Market
Table 3. Sarcopenia Treatments Market Restraints in United States Market
Table 4. Key Players of Sarcopenia Treatments in United States Market
Table 5. Top Sarcopenia Treatments Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Sarcopenia Treatments Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Sarcopenia Treatments Revenue Share by Companies, 2016-2021
Table 8. Companies Sarcopenia Treatments Product Type
Table 9. List of Tier 1 Sarcopenia Treatments Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Sarcopenia Treatments Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Sarcopenia Treatments Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Sarcopenia Treatments Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Sarcopenia Treatments Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Sarcopenia Treatments Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Sarcopenia Treatments Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Sarcopenia Treatments Revenue (US$, Mn), 2022-2027
Table 17. Abbott Laboratories Company Details
Table 18. Abbott Laboratories Business Overview
Table 19. Abbott Laboratories Sarcopenia Treatments Product
Table 20. Abbott Laboratories Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Abbott Laboratories Recent Developments
Table 22. Nestlé Company Details
Table 23. Nestlé Business Overview
Table 24. Nestlé Sarcopenia Treatments Product
Table 25. Nestlé Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Nestlé Recent Developments
Table 27. Pfizer Company Details
Table 28. Pfizer Business Overview
Table 29. Pfizer Sarcopenia Treatments Product
Table 30. Pfizer Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Pfizer Recent Developments
Table 32. Amway Company Details
Table 33. Amway Business Overview
Table 34. Amway Sarcopenia Treatments Product
Table 35. Amway Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Amway Recent Developments
Table 37. By-health Company Details
Table 38. By-health Business Overview
Table 39. By-health Sarcopenia Treatments Product
Table 40. By-health Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. By-health Recent Developments
Table 42. Usana Company Details
Table 43. Usana Business Overview
Table 44. Usana Sarcopenia Treatments Product
Table 45. Usana Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Usana Recent Developments
Table 47. A&Z Pharmaceutical Company Details
Table 48. A&Z Pharmaceutical Business Overview
Table 49. A&Z Pharmaceutical Sarcopenia Treatments Product
Table 50. A&Z Pharmaceutical Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. A&Z Pharmaceutical Recent Developments
Table 52. GlaxoSmithKline Company Details
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Sarcopenia Treatments Product
Table 55. GlaxoSmithKline Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. GlaxoSmithKline Recent Developments
Table 57. Bayer Company Details
Table 58. Bayer Business Overview
Table 59. Bayer Sarcopenia Treatments Product
Table 60. Bayer Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Bayer Recent Developments
Table 62. H&H Company Details
Table 63. H&H Business Overview
Table 64. H&H Sarcopenia Treatments Product
Table 65. H&H Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. H&H Recent Developments
Table 67. Blackmores Company Details
Table 68. Blackmores Business Overview
Table 69. Blackmores Sarcopenia Treatments Product
Table 70. Blackmores Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Blackmores Recent Developments
Table 72. Zhendong Group Company Details
Table 73. Zhendong Group Business Overview
Table 74. Zhendong Group Sarcopenia Treatments Product
Table 75. Zhendong Group Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Zhendong Group Recent Developments
List of Figures
Figure 1. Sarcopenia Treatments Segment by Type
Figure 2. Sarcopenia Treatments Segment by Application
Figure 3. United States Sarcopenia Treatments Market Overview: 2020
Figure 4. United States Sarcopenia Treatments Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Sarcopenia Treatments Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Sarcopenia Treatments Revenue in 2020
Figure 7. By Type - United States Sarcopenia Treatments Revenue Market Share, 2016-2027
Figure 8. By Application - United States Sarcopenia Treatments Revenue Market Share, 2016-2027
Figure 9. Abbott Laboratories Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Nestlé Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Pfizer Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Amway Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. By-health Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Usana Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. A&Z Pharmaceutical Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. GlaxoSmithKline Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Bayer Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. H&H Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Blackmores Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Zhendong Group Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs